Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About RTI Biologics Inc. (RTIX)

Page 1 of 2

RTI Biologics Inc. (NASDAQ:RTIX) has seen a decrease in support from the world’s most elite money managers recently.

To the average investor, there are tons of methods shareholders can use to track the equity markets. Some of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top money managers can outperform the broader indices by a very impressive amount (see just how much).

Chuck RoyceEqually as important, bullish insider trading activity is another way to break down the investments you’re interested in. Just as you’d expect, there are plenty of stimuli for a corporate insider to cut shares of his or her company, but just one, very simple reason why they would behave bullishly. Various empirical studies have demonstrated the valuable potential of this strategy if “monkeys” know what to do (learn more here).

With these “truths” under our belt, we’re going to take a peek at the key action encompassing RTI Biologics Inc. (NASDAQ:RTIX).

Hedge fund activity in RTI Biologics Inc. (NASDAQ:RTIX)

At Q1’s end, a total of 12 of the hedge funds we track were bullish in this stock, a change of -14% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were boosting their holdings significantly.

When looking at the hedgies we track, Chuck Royce’s Royce & Associates had the biggest position in RTI Biologics Inc. (NASDAQ:RTIX), worth close to $3.7 million, comprising less than 0.1%% of its total 13F portfolio. Sitting at the No. 2 spot is Renaissance Technologies, managed by Jim Simons, which held a $2.3 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining hedgies that are bullish include Jeffrey Vinik’s Vinik Asset Management, Robert B. Gillam’s McKinley Capital Management and D. E. Shaw’s D E Shaw.

Due to the fact that RTI Biologics Inc. (NASDAQ:RTIX) has faced a declination in interest from the smart money, logic holds that there was a specific group of money managers who were dropping their positions entirely last quarter. Intriguingly, Mark Broach’s Manatuck Hill Partners cut the biggest stake of the 450+ funds we track, comprising close to $2.1 million in stock.. Peter Algert and Kevin Coldiron’s fund, Algert Coldiron Investors, also cut its stock, about $1.4 million worth. These moves are important to note, as total hedge fund interest fell by 2 funds last quarter.

What have insiders been doing with RTI Biologics Inc. (NASDAQ:RTIX)?

Insider trading activity, especially when it’s bullish, is most useful when the primary stock in question has seen transactions within the past 180 days. Over the latest six-month time period, RTI Biologics Inc. (NASDAQ:RTIX) has seen zero unique insiders purchasing, and 1 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to RTI Biologics Inc. (NASDAQ:RTIX). These stocks are Hansen Medical, Inc. (NASDAQ:HNSN), Cryolife Inc (NYSE:CRY), Exactech, Inc. (NASDAQ:EXAC), Palomar Medical Technologies Inc (NASDAQ:PMTI), and Cutera, Inc. (NASDAQ:CUTR). This group of stocks belong to the medical appliances & equipment industry and their market caps are similar to RTIX’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!